ArticleBreast cancer (Dove Medical Press)2023

The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models.

Wenyu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.